Position
BARCLAYS PLC in Vaxcyte, Inc.
Back to the book · All holders of PCVX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $382.9K$46.14 → $58.11
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2022 | 113.9K | $5.46M | — | — | — | 0.0% |
| Q1 2023 | 92.2K | $3.46M | $37.48 | −$965.4K | −$1.04M | 0.0% |
| Q2 2023 | 101.5K | $5.07M | $49.94 | $1.15M | $464.6K | 0.0% |
| Q3 2023 | 170.4K | $8.69M | $50.98 | $105.6K | $3.51M | 0.0% |
| Q4 2023 | 201.7K | $12.7M | $62.80 | $2.01M | $1.96M | 0.0% |
| Q1 2024 | 129.3K | $8.83M | $68.31 | $712.2K | −$4.55M | 0.0% |
| Q2 2024 | 128K | $9.66M | $75.51 | $921.3K | −$88.8K | 0.0% |
| Q3 2024 | 209.8K | $24M | $114.27 | $4.96M | $9.35M | 0.0% |
| Q4 2024 | 254.9K | $20.9M | $81.86 | −$6.8M | $3.69M | 0.0% |
| Q1 2025 | 226.1K | $8.54M | $37.76 | −$9.97M | −$2.35M | 0.0% |
| Q2 2025 | 438.4K | $14.3M | $32.51 | −$1.19M | $6.9M | 0.0% |
| Q3 2025 | 393.9K | $14.2M | $36.02 | $1.38M | −$1.45M | 0.0% |
| Q4 2025 | 296.2K | $13.7M | $46.14 | $3M | −$3.52M | 0.0% |
| Q1 2026 | 32K | $1.86M | $58.11 | $382.9K | −$12.2M | 0.0% |